Publications dans lesquelles il/elle collabore avec Antonio López Borrasca (35)

1993

  1. Multiparameter analysis of blast cells in patients with acute leukemia following a primary myelodysplastic syndrome.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, Vol. 131, pp. 393-400

1992

  1. Development of acute leukaemia after idiopathic myelofibrosis

    Journal of Clinical Pathology, Vol. 45, Núm. 5, pp. 427-430

  2. Long‐term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study

    British Journal of Haematology, Vol. 82, Núm. 4, pp. 671-675

  3. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia

    Leukemia, Vol. 6, Núm. 1, pp. 47-51

1991

  1. Antibodies against hepatitis C virus in hemophiliacs: correlation with peripheral blood lymphocyte populations

    Medicina clínica, Vol. 96, Núm. 3, pp. 81-84

  2. Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes

    Medicina clínica, Vol. 97, Núm. 10, pp. 369-372

  3. Heterogeneity of T cell lymphoblastic leukaemias

    Journal of Clinical Pathology, Vol. 44, Núm. 8, pp. 628-631

  4. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia

    British Journal of Haematology, Vol. 79, Núm. 3, pp. 408-414

  5. Phenotypic changes in refractory and relapse acute lymphoblastic leukemias

    Sangre, Vol. 36, Núm. 3, pp. 201-204

  6. Study of leukaemic colony forming unity. Its relationship with morphologic and immunological classification

    Oncologia, Vol. 14, Núm. 2, pp. 97-100

1990

  1. Clinical and phenotypical characteristics of pre-T-cell leukemia

    Blood

  2. Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia.

    Haematologia, Vol. 23, Núm. 1, pp. 49-56

  3. Usefulness of the immunologic phenotype in the diagnosis of chronic lymphoproliferative syndromes with splenomegaly as the dominant clinical manifestation

    Sangre, Vol. 35, Núm. 5, pp. 369-373

1989

  1. Prognostic value of immunological markers in acute myeloblastic leukemia

    Leukemia, Vol. 3, Núm. 2, pp. 108-111

1988

  1. Acción del medio condicionado leucocitario con PHA sobre la proliferación y diferenciación de las células leucémicas.

    Sangre, Vol. 33, Núm. 1, pp. 15-19

  2. Estudio comparativo entre la clasificación FAB y un modelo de clasificación inmunológica para las leucemias mieloides agudas.

    Sangre, Vol. 33, Núm. 4, pp. 291-295

  3. Leucemia linfática crónica B: anemias hemolíticas autoinmunes versus anemias debidas a un fallo medular.

    Sangre, Vol. 33, Núm. 4, pp. 296-300

  4. Leukemias with megakaryoblastic involvement: Clinical, hematologic, and immunologic characteristics

    Blood, Vol. 72, Núm. 2, pp. 402-407

1987

  1. Cell lineage switches in blast crisis of a Ph1 positive chronic granulocytic leukemia

    Haematologica, Vol. 72, Núm. 3, pp. 249-251

  2. Discrepancies between morphologic, cytochemical, and immunologic characteristics in acute myeloblastic leukemia

    American Journal of Clinical Pathology, Vol. 88, Núm. 1, pp. 38-42